Table 1.
Agents | Dose | Route | Timing of treatment |
---|---|---|---|
DDGP | |||
Pegaspargase | 2,500 IU/m2 | i.m. | Day 1 |
Gemcitabine | 800 mg/m2 | i.v. | Days 1 and 8 |
Cisplatin | 20 mg/m2 | i.v. | Days 1–4 |
Dexamethasone | 15 mg/m2 | i.v. | Days 1–5 |
SMILE | |||
Methotrexate | 2 g/m2 | i.v. (6 hours) | Day 1 |
Dexamethasone | 40 mg/m2 | i.v. | Days 2–4 |
Ifosfamide | 1,500 mg/m2 | i.v. | Days 2–4 |
Mesna | 300 mg/m2 × 3 | i.v. | Days 2–4 |
Etoposide | 100 mg/m2 | i.v. | Days 2–4 |
L‐asparaginase | 6,000 U/m2 | i.v. | Days 3–9 |
or Pegaspargase | 2,500 IU/m2 | i.m. | Day 3 |
Cycles of DDGP and SMILE regimen were repeated every 21 days.
DDGP, cisplatin, dexamethasone, gemcitabine, and pegaspargase; SMILE, methotrexate, dexamethasone, ifosfamide, L‐asparaginase, and etoposide.